By: Zosia Chustecka From Medscape Medical News August 20, 2008 — “There is good reason to be cautious about introducing large-scale vaccination programs” with the human papillomavirus (HPV) vaccines, because many essential questions are still unanswered. This is the conclusion of Charlotte Haug, MD, PhD, from the Journal of the Norwegian Medical Association, in […]
Anaphylaxis following quadrivalent human papillomavirus vaccination.
By: Julia M.L. Brotherton, MD HPH, et al Published at www.cmaj.ca on Sept. 1, 2008. Background: In 2007, Australia implemented the National human papillomavirus (HPV) Vaccination Program, which provides quadrivalent HPV vaccine free to all women aged 12–26 years. Following notification of 7 presumptive cases of anaphylaxis in the state of New South Wales, […]
The Risks and Benefits of HPV Vaccination
Charlotte Haug, MD, PhD, MSc JAMA. 2009;302(7):795-796. When do physicians know enough about the beneficial effectsof a new medical intervention to start recommending or usingit? When is the available information about harmful adverseeffects sufficient to conclude that the risks outweigh the potentialbenefits? If in doubt, should physicians err on the side ofcaution or on the side […]
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.
JAMA. 2009 Aug 19;302(7):750-7. Abstract CONTEXT: In June 2006, the Food and Drug Administration licensed the quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccine (qHPV) in the United States for use in females aged 9 to 26 years; the Advisory Committee on Immunization Practices then recommended qHPV for routine vaccination of […]
Reports of Autoimmune Disorders After HPV Vaccine Raise Questions
From Medscape Medical News September 23, 2009 (Düsseldorf, Germany) — Investigators have identified cases of autoimmune disorders after immunization with the quadrivalent vaccine Gardasil. The Merck product is designed to prevent infection with several types of human papillomavirus. Presenting here at the 25th Congress of the European Committee for Treatment and Research in Multiple […]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- Next Page »